University of Ulm-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2018

  1. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia - Update on methodological approaches and results interpretation

    Leukemia, Vol. 32, Núm. 5, pp. 1070-1080

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

    Nature Genetics, Vol. 47, Núm. 2, pp. 164-171

2011

  1. Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma

    Haematologica, Vol. 96, Núm. 2, pp. 238-244

2010

  1. Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome

    Atherosclerosis, Vol. 209, Núm. 1, pp. 300-305

2009

  1. Wound healing defect of Vav3-/- mice due to impaired β2-integrin-dependent macrophage phagocytosis of apoptotic neutrophils

    Blood, Vol. 113, Núm. 21, pp. 5266-5276

2008

  1. Interleukin-12 inhibits liver-specific drug-inducible systems in vivo

    Gene Therapy, Vol. 15, Núm. 4, pp. 277-288

2002

  1. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

    Blood, Vol. 100, Núm. 12, pp. 3877-3886